Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
105.3 USD | -0.59% | -5.55% | -4.36% |
Apr. 18 | Correction to Health Care Roundup Article | DJ |
Apr. 18 | RBC Lowers Price Target on Abbott Laboratories to $125 From $128, Keeps Outperform Rating | MT |
Financials (USD)
Sales 2024 * | 41.72B | Sales 2025 * | 44.79B | Capitalization | 184B |
---|---|---|---|---|---|
Net income 2024 * | 5.92B | Net income 2025 * | 7.15B | EV / Sales 2024 * | 4.54 x |
Net Debt 2024 * | 5.5B | Net cash position 2025 * | 862M | EV / Sales 2025 * | 4.08 x |
P/E ratio 2024 * |
30.8
x | P/E ratio 2025 * |
26.3
x | Employees | 114,000 |
Yield 2024 * |
2.06% | Yield 2025 * |
2.2% | Free-Float | 86.77% |
Latest transcript on Abbott Laboratories
1 day | +0.55% | ||
1 week | -5.55% | ||
Current month | -7.38% | ||
1 month | -6.38% | ||
3 months | -7.67% | ||
6 months | +10.16% | ||
Current year | -4.36% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | 14-12-31 |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 96-12-31 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 89-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Starks
BRD | Director/Board Member | 69 | 17-02-15 |
John Stratton
BRD | Director/Board Member | 63 | 17-06-28 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 11-12-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.18% | 18 M€ | +2.12% | - | |
5.19% | 2 M€ | -.--% | ||
3.00% | 2 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 105.3 | -0.59% | 7,302,045 |
24-04-17 | 105.9 | -3.03% | 12,002,886 |
24-04-16 | 109.2 | +0.29% | 7,283,867 |
24-04-15 | 108.9 | -0.20% | 4,595,628 |
24-04-12 | 109.1 | -2.10% | 4,041,615 |
Delayed Quote Nyse, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.36% | 184B | |
-3.87% | 105B | |
-4.38% | 67.09B | |
+8.23% | 51.61B | |
+15.54% | 47.55B | |
-0.85% | 39.95B | |
+7.16% | 27.62B | |
-12.48% | 25.74B | |
-1.68% | 25.62B | |
+10.34% | 24.93B |
- Stock Market
- Equities
- ABT Stock